Literature DB >> 28422508

Nitrile in the Hole: Discovery of a Small Auxiliary Pocket in Neuronal Nitric Oxide Synthase Leading to the Development of Potent and Selective 2-Aminoquinoline Inhibitors.

Maris A Cinelli1, Huiying Li2, Georges Chreifi2, Thomas L Poulos2, Richard B Silverman1.   

Abstract

Neuronal nitric oxide synthase (nNOS) inhibition is a promising strategy to treat neurodegenerative disorders, but the development of nNOS inhibitors is often hindered by poor pharmacokinetics. We previously developed a class of membrane-permeable 2-aminoquinoline inhibitors and later rearranged the scaffold to decrease off-target binding. However, the resulting compounds had decreased permeability, low human nNOS activity, and low selectivity versus human eNOS. In this study, 5-substituted phenyl ether-linked aminoquinolines and derivatives were synthesized and assayed against purified NOS isoforms. 5-Cyano compounds are especially potent and selective rat and human nNOS inhibitors. Activity and selectivity are mediated by the binding of the cyano group to a new auxiliary pocket in nNOS. Potency was enhanced by methylation of the quinoline and by introduction of simple chiral moieties, resulting in a combination of hydrophobic and auxiliary pocket effects that yielded high (∼500-fold) n/e selectivity. Importantly, the Caco-2 assay also revealed improved membrane permeability over previous compounds.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28422508      PMCID: PMC5567828          DOI: 10.1021/acs.jmedchem.7b00259

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  58 in total

1.  Symmetric double-headed aminopyridines, a novel strategy for potent and membrane-permeable inhibitors of neuronal nitric oxide synthase.

Authors:  Fengtian Xue; Jianguo Fang; Silvia L Delker; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2011-03-16       Impact factor: 7.446

Review 2.  Role of nitric oxide in Parkinson's disease.

Authors:  Li Zhang; Valina L Dawson; Ted M Dawson
Journal:  Pharmacol Ther       Date:  2005-07-07       Impact factor: 12.310

3.  Characterization of recombinant human endothelial nitric-oxide synthase purified from the yeast Pichia pastoris.

Authors:  A Leber; B Hemmens; B Klösch; W Goessler; G Raber; B Mayer; K Schmidt
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

4.  iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM.

Authors:  T Geoff G Battye; Luke Kontogiannis; Owen Johnson; Harold R Powell; Andrew G W Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

5.  Pd/C(en) catalyzed chemoselective hydrogenation in the presence of aryl nitriles.

Authors:  Tomohiro Maegawa; Yuki Fujita; Ai Sakurai; Akira Akashi; Mutsumi Sato; Keiji Oono; Hironao Sajiki
Journal:  Chem Pharm Bull (Tokyo)       Date:  2007-05       Impact factor: 1.645

6.  A general, practical palladium-catalyzed cyanation of (hetero)aryl chlorides and bromides.

Authors:  Todd D Senecal; Wei Shu; Stephen L Buchwald
Journal:  Angew Chem Int Ed Engl       Date:  2013-08-09       Impact factor: 15.336

7.  A general and efficient 2-amination of pyridines and quinolines.

Authors:  Jingjun Yin; Bangping Xiang; Mark A Huffman; Conrad E Raab; Ian W Davies
Journal:  J Org Chem       Date:  2007-05-15       Impact factor: 4.354

8.  Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase.

Authors:  Z Huang; P L Huang; N Panahian; T Dalkara; M C Fishman; M A Moskowitz
Journal:  Science       Date:  1994-09-23       Impact factor: 47.728

Review 9.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  7 in total

1.  Hydrophilic, Potent, and Selective 7-Substituted 2-Aminoquinolines as Improved Human Neuronal Nitric Oxide Synthase Inhibitors.

Authors:  Anthony V Pensa; Maris A Cinelli; Huiying Li; Georges Chreifi; Paramita Mukherjee; Linda J Roman; Pavel Martásek; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2017-08-04       Impact factor: 7.446

2.  Improvement of Cell Permeability of Human Neuronal Nitric Oxide Synthase Inhibitors Using Potent and Selective 2-Aminopyridine-Based Scaffolds with a Fluorobenzene Linker.

Authors:  Ha T Do; Heng-Yen Wang; Huiying Li; Georges Chreifi; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2017-11-01       Impact factor: 7.446

3.  2-Aminopyridines with a shortened amino sidechain as potent, selective, and highly permeable human neuronal nitric oxide synthase inhibitors.

Authors:  Dhananjayan Vasu; Huiying Li; Christine D Hardy; Thomas L Poulos; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2022-06-11       Impact factor: 3.461

4.  A Small Peptide Increases Drug Delivery in Human Melanoma Cells.

Authors:  Shirley Tong; Shaban Darwish; Hanieh Hossein Nejad Ariani; Kate Alison Lozada; David Salehi; Maris A Cinelli; Richard B Silverman; Kamaljit Kaur; Sun Yang
Journal:  Pharmaceutics       Date:  2022-05-11       Impact factor: 6.525

5.  First Contact: 7-Phenyl-2-Aminoquinolines, Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors That Target an Isoform-Specific Aspartate.

Authors:  Maris A Cinelli; Cory T Reidl; Huiying Li; Georges Chreifi; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2020-04-17       Impact factor: 7.446

6.  Structural Basis for Isoform Selective Nitric Oxide Synthase Inhibition by Thiophene-2-carboximidamides.

Authors:  Huiying Li; Ryan J Evenson; Georges Chreifi; Richard B Silverman; Thomas L Poulos
Journal:  Biochemistry       Date:  2018-10-24       Impact factor: 3.162

7.  Inhibition of interferon-gamma-stimulated melanoma progression by targeting neuronal nitric oxide synthase (nNOS).

Authors:  Shirley Tong; Maris A Cinelli; Naglaa Salem El-Sayed; He Huang; Anika Patel; Richard B Silverman; Sun Yang
Journal:  Sci Rep       Date:  2022-02-01       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.